
Chronic myelogenous leukaemia (CML) is an uncommon bone marrow malignancy. Bone marrow is the spongy substance found inside bones that produces blood cells. CML increases the quantity of white blood cells in the bloodstream.
The term chronic in chronic myelogenous leukaemia refers to cancer that progresses more slowly than severe kinds of leukaemia. The term myelogenous relates to the cells affected by this malignancy.
Chronic myelogenous leukaemia is also known as chronic myeloid or chronic granulocytic leukaemia. It mainly affects older adults and is infrequently seen in children, but it can happen at any age.
Advances in treatment have improved the prognosis for persons with chronic myelogenous leukaemia.
Chronic myelogenous leukaemia is generally asymptomatic. A blood test may identify it. Symptoms may include:
Causes
Chronic myelogenous leukaemia occurs when something changes the bone marrow cells.
A new chromosome develops.
The Philadelphia chromosome generates a new gene.
The new gene allows for too many unhealthy blood cells
Risk Factors
The following factors enhance the risk of chronic myelogenous leukaemia:
Complications
Individuals with CML may develop:
Some prevention tips for Chronic Myeloid Leukaemia (CML):
These tips support overall health but cannot specifically prevent CML.
Targeted therapy: Targeted therapy focuses on specific molecules in cancer cells, such as the tyrosine kinase protein in chronic myelogenous leukaemia.
Cost Start From USD 10000 - USD 50000Explore Options
Bone marrow transplant: A bone marrow transplant heals chronic myelogenous leukaemia, although it is only recommended for patients who have not received previous treatments due to the dangers and problems involved. High-dose chemotherapy destroys blood-forming cells, while donor blood stem cells replace damaged ones.
Cost Start From USD 120000 - USD 150000Explore Options
Chemotherapy: Chemotherapy employs potent medications to attack cancer cells. Chemotherapy medicines are occasionally coupled with targeted therapy to treat aggressive, chronic myelogenous leukaemia.
Cost Start From USD 36600 - USD 0Explore Options
The following tests and procedures diagnose Chronic myeloid leukaemia (CML):
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Novena, Singapore
Mount Elizabeth Novena Hospital located in Novena, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Singapore, Singapore
Parkway East Hospital located in Joo Chiat Pl, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Singapore, Singapore
Mount Elizabeth Hospital located in Singapore, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Singapore:
Treatment for Chronic Myeloid Leukaemia (CML) is quite successful in Singapore, with a five-year survival rate of 86%. However, resistance may necessitate therapeutic modifications for 30 to 50% of patients. Treatment adherence greatly enhances results, particularly when significant molecular responses are attained.
Although recurrence is uncommon, it can occur, particularly if the disease is not adequately controlled or the patient grows resistant to treatment. Regular monitoring and treatment changes can manage relapsed CML.
Side effects differ depending on the specific tyrosine kinase inhibitors (TKIs), but may include:
Indeed, numerous specialised clinics in Singapore treat Chronic Myeloid Leukaemia (CML). These facilities provide specialised haematologists and oncologists, targeted therapies including tyrosine kinase inhibitors (TKIs) and state-of-the-art diagnostic methods. Patients with CML can receive comprehensive care from these hospitals, which includes access to clinical research and individualised treatment strategies.
Yes, it can. CML patients may be more likely to develop other types of cancer (second malignancies). A recent study found that approximately 30% of persons with chronic myeloid leukaemia got second malignancies, including:
Although there is no clear regional pattern for chronic myeloid leukaemia (CML) in Singapore, urban regions may have a higher frequency. According to certain studies, certain ethnic groups also have greater rates.
In Singapore, patients with severe stages of Chronic Myeloid Leukaemia (CML) or those who do not respond to tyrosine kinase inhibitors (TKIs) are treated with stem cell transplants, also referred to as bone marrow transplants.
Especially for patients with high-risk or drug-resistant CML, this treatment may result in a cure. For optimal outcomes, Singapore's cutting-edge healthcare system makes stem cell transplantation possible through specialised clinics.